Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VIR compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name
VIR
Vir Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VIR
Vir Biotechnology, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
VIR
with
LYEL
No shared trading history for VIR and LYEL.
Shared co-movers: not yet measured (LYEL).
VIR, solid
LYEL, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
VIR
Vir Biotechnology, Inc.
Change
11.02
▼
−2.52%
· post 11.02
Mkt cap
$1.9B
Revenue
$239M
Q2 FY26
Revenue
$74M
FY24
LYEL
Lyell Immunopharma, Inc.
Change
10.69
▼
−3.14%
· post 10.69
Closed
Nov 2 '26
Mkt cap
$270.5M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
vs
Compare
Closed
Nov 2 '26
VIR
Vir Biotechnology, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
11.02
▼
−2.52%
post 11.02
Price
10.69
▼
−3.14%
post 10.69
$1.9B
Mkt cap
$270.5M
Q2 FY26
$239M
Revenue
$4,000
Q2 FY26
FY24
$74M
Revenue
$36,000
FY25
Change
Change
VIR
11.02
▼
−2.52%
vs
LYEL
10.69
▼
−3.14%
Closed
Nov 2 '26